We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
Cap. Flow
+$1.55B
Cap. Flow %
8.12%
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$89.1M
2
WEX icon
WEX
WEX
+$78.4M
3
BLK icon
Blackrock
BLK
+$73.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$71.9M
5
OMF icon
OneMain Financial
OMF
+$45.3M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$63.6M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$56.6M
3
AEM icon
Agnico Eagle Mines
AEM
+$55.1M
4
DFS
Discover Financial Services
DFS
+$36M
5
ORBC
ORBCOMM, Inc.
ORBC
+$27.5M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 14.65%
3 Healthcare 12.11%
4 Consumer Discretionary 7.54%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSI
2851
DELISTED
Life Storage, Inc.
LSI
$11K ﹤0.01%
97
– –
SGTX
2852
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$11K ﹤0.01%
+154
New +$11.9K
DEX
2853
DELISTED
DELAWARE ENHANCED GLOBAL DIVIDEND & INCOME FUND
DEX
$11K ﹤0.01%
1,160
-967
-45% -$10.1K
FVT.WS
2854
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$11K ﹤0.01%
13,920
+1,997
+17% +$2.19K
MANT
2855
DELISTED
Mantech International Corp
MANT
$11K ﹤0.01%
157
-132
-46% -$10.8K
TLMD
2856
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$11K ﹤0.01%
+5,000
New +$18K
FRTA
2857
DELISTED
Forterra, Inc
FRTA
$11K ﹤0.01%
500
– –
DMYI.U
2858
DELISTED
dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
DMYI.U
$11K ﹤0.01%
+1,000
New +$10.9K
ABCL icon
2859
AbCellera Biologics
ABCL
$2.12B
$10K ﹤0.01%
+500
New +$8.84K
ADAP
2860
DELISTED
Adaptimmune Therapeutics
ADAP
$10K ﹤0.01%
2,000
– –
BKU icon
2861
Bankunited
BKU
$3.36B
$10K ﹤0.01%
257
-61
-19% -$2.5K
BYRN icon
2862
Byrna Technologies
BYRN
$101M
$10K ﹤0.01%
500
– –
CBSH icon
2863
Commerce Bancshares
CBSH
$8.5B
$10K ﹤0.01%
202
-1,516
-88% -$83.6K
CVM icon
2864
CEL-SCI Corp
CVM
$30.1M
$10K ﹤0.01%
32
-20
-38% -$5.83K
DBL
2865
DoubleLine Opportunistic Credit Fund
DBL
$280M
$10K ﹤0.01%
531
+2
+0.4% +$40
DDIV icon
2866
First Trust Exchange-Traded Fund VI First Trust Dorsey Wright Momentum & Dividend ETF
DDIV
$80.2M
$10K ﹤0.01%
330
+2
+0.6% +$62
AXIA
2867
DELISTED
AXIA Energia
AXIA
$10K ﹤0.01%
+1,846
New +$11.2K
EBS icon
2868
Emergent Biosolutions
EBS
$248M
$10K ﹤0.01%
200
-12
-6% -$727
EIDO icon
2869
iShares MSCI Indonesia ETF
EIDO
$501M
$10K ﹤0.01%
+500
New +$10.4K
ELDN icon
2870
Eledon Pharmaceuticals
ELDN
$285M
$10K ﹤0.01%
1,666
– –
FLS icon
2871
Flowserve
FLS
$10.2B
$10K ﹤0.01%
292
-5
-2% -$196
FOLD
2872
DELISTED
Amicus Therapeutics
FOLD
$10K ﹤0.01%
1,145
-69
-6% -$706
GNTX icon
2873
Gentex
GNTX
$5.07B
$10K ﹤0.01%
327
+209
+177% +$6.75K
HOPE icon
2874
Hope Bancorp
HOPE
$1.79B
$10K ﹤0.01%
714
+81
+13% +$1.1K
IDE
2875
Voya Infrastructure, Industrials and Materials Fund
IDE
$198M
$10K ﹤0.01%
836
-182
-18% -$2.36K
113 114
115
116 117

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.

  • Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
  • Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
  • Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
  • Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
  • Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
  • Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
  • Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.